home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

3rd Annual Therapeutic Strategies against Neurodegenerative Conditions

 
  September 06, 2007  
     
 
GTCbio, San Francisco, CA
09-20 to 09-21-2007


Neurodegenerative diseases such as Alzheimer`s and Parkinson`s disease and conditions such as stroke disrupt the quality of life for patients, extracts an enormous emotional and physical strain on caregivers, and cost society billions of dollars annually. Increasing numbers of elderly people in the population has resulted in a sharp increase in the prevalence of these neurological conditions. Underlying a majority of these disorders is the abnormal degeneration of neurons. In most instances, the etiological causes are unknown and they have a progressive development. While symptomatic treatments are available for many neurodegenerative disorders, drugs to reduce or prevent the neuronal loss in patients have yet to be identified. Intense research over the past few years has generated a rich and complex body of information about the mechanisms and pathophysiology of neurodegenerative conditions. This knowledge has provided the opportunity to find novel targets for drug development and resulting in the initiation of several promising clinical trials.

The conference focuses on the latest and most exciting research findings in the identification of novel molecular targets and the development of potential therapeutic strategies for neurodegenerative conditions. In the 1st and 2nd annual conferences, we have had excellent list of speakers from academia, industry and government whose presentations covered a range of topics within the area of neurodegeneration and therapy and with information from cell culture models to clinical trials.

The 3rd annual conference will take place on Thursday, Sept 20 and Friday, Sept 21 in San Francisco, California. Please bring this conference to the attention of your colleagues who may benefit from attending the meeting. Please register early and submit an abstract.

It is our pleasure to welcome you to the 3rd annual conference on Therapeutic Strategies against Neurodegenerative Conditions in San Francisco.

 
 
Organized by: GTCbio
Invited Speakers: Eric Karran [Keynote Speaker]
Chief Scientific Officer, Neurodegenerative Diseases Drug Hunting Team
Eli Lilly & Co.

Marcelle Bergeron
Principal Scientist, Department of Neuroscience
Amgen

J. Steven Jacobsen
Associate Director, Neuroscience Discovery
Wyeth Research

Jennifer Johnston
Principal Scientist
Elan Pharmaceuticals

Grant Kraft
Chairman and Chief Science Officer
Acumen Pharmaceuticals, Inc.

Jinhe Li
Neuroscience Research
Abbott Laboratories

Ambreena Siddiq
Neuroprotection Research Laboratory
Burke-Cornell Medical Research Institute

James Simpkins
Professor and Department Chair
University of North Texas Health Science Center

Frank La Ferla
Co-Director
Institute for Brain Aging and Dementia

Robert Freeman
Associate Professor, Director,
Interdepartmental Graduate Program in Neuros
University of Rochester School of Medicine
Peter H. Reinhart, Ph.D.
Senior Director, Neurodegeneration
Wyeth Research

Manisha Patel
University of Colorado Health Sciences Center


Massimiliano Bianchi
MAPREG


Brett Langley
Burke-Cornell Medical Research Institute


David Lowe
CSO, Memory Pharmaceuticals Corporation


Santosh R. D'Mello
Professor, University of Dallas


Jacqueline Kirchner
Principal Scientist, Amgen


Joseph D. Buxbaum
Mount Sinai School of Medicine


Julie Andersen
Professor, Buck Institute for Age Research


Michael Weiner
ADNI Principal Investigator, University of California, San Francisco


Jianhua Zhang
University of Alabama at Birmingham


Diane Stephenson
Associate Research Fellow, Pfizer


Seth P. Finklestein, M.D.
Chief Executive Officer
Biotrofix, Inc.

Peter Seubert, Ph.D.
Vice President, Neurodegeneration Research
Elan Pharmaceuticals

Ronald B. Demattos
Neuroscience Discovery Research
Eli Lilly & Company

William H. Frey II, Ph.D.
Director, Alzheimer's Research Center
Regions Hospital

Daniel Figeys
Canada Research Chair in Proteomics and Systems Biology
University of Ottawa

David S. Park, M.D. [Advisor]
Associate Professor
Ottawa Health Research Institute

Ted Dawson [Advisor]
Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases
Institute for Cell Engineering, Depts of Neurology and Neuroscience
Johns Hopkins University School of Medicine
Debomoy Lahiri [Advisor]
Institute of Psychiatric Research, Department of Psychiatry
Indiana University School of Medicine

 
Deadline for Abstracts: August 20, 2007
 
Registration: please visit the following website for registration information: https://ssl.nshosts.com/gtcbiocom/conference/userpart/user_registration.aspx?id=10
E-mail: vivian.frankel@gtcbio.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.